ATE398677T1 - Antigene aus streptococcus pyogenes und zugehörige dna-fragmente - Google Patents

Antigene aus streptococcus pyogenes und zugehörige dna-fragmente

Info

Publication number
ATE398677T1
ATE398677T1 AT01271387T AT01271387T ATE398677T1 AT E398677 T1 ATE398677 T1 AT E398677T1 AT 01271387 T AT01271387 T AT 01271387T AT 01271387 T AT01271387 T AT 01271387T AT E398677 T1 ATE398677 T1 AT E398677T1
Authority
AT
Austria
Prior art keywords
antigens
streptococcus pyogenes
dna fragments
associated dna
streptococcus
Prior art date
Application number
AT01271387T
Other languages
English (en)
Inventor
Denis Martin
Bernard R Brodeur
Josee Hamel
Stephane Rioux
Patrick Rheault
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Application granted granted Critical
Publication of ATE398677T1 publication Critical patent/ATE398677T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
AT01271387T 2000-12-21 2001-12-21 Antigene aus streptococcus pyogenes und zugehörige dna-fragmente ATE398677T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25694000P 2000-12-21 2000-12-21

Publications (1)

Publication Number Publication Date
ATE398677T1 true ATE398677T1 (de) 2008-07-15

Family

ID=22974225

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01271387T ATE398677T1 (de) 2000-12-21 2001-12-21 Antigene aus streptococcus pyogenes und zugehörige dna-fragmente

Country Status (12)

Country Link
US (5) US7595057B2 (de)
EP (1) EP1343895B1 (de)
JP (1) JP4080876B2 (de)
AT (1) ATE398677T1 (de)
AU (2) AU2002216863B8 (de)
BE (1) BE2021C506I2 (de)
BR (1) BR0116704A (de)
CA (2) CA2789252C (de)
DE (1) DE60134494D1 (de)
ES (1) ES2307564T3 (de)
FR (1) FR21C1005I2 (de)
WO (1) WO2002050107A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
US20070110763A1 (en) * 2003-08-15 2007-05-17 Stephane Rioux Polypeptides of streptococcus pyogenes
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6287574B1 (en) 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
HU228497B1 (en) * 1998-02-20 2013-03-28 Id Biomedical Corp Quebec Group b steptococcus antigens
GB9807890D0 (en) 1998-04-09 1998-06-10 Actinova Ltd Peptides
JP2002531055A (ja) 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド 肺炎連鎖球菌のタンパク質及び核酸分子
WO2000006736A2 (en) 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9828880D0 (en) 1998-12-31 1999-02-17 Actinova Ltd Protein
US7074415B2 (en) * 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
CA2413576C (en) * 2000-07-06 2012-11-13 Shire Biochem Inc. Streptococcus pyogenes antigens
JP4102186B2 (ja) * 2000-10-13 2008-06-18 アイディー バイオメディカル コーポレイション グループｂストレプトコッカスのｂｖｈ−ａ２及びｂｖｈ−ａ３抗原
EP2189473A3 (de) * 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Nukleinsäure und Proteine von Gruppen A und B Streptokokken
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
ATE456659T1 (de) * 2001-02-21 2010-02-15 Id Biomedical Corp Streptococcus pyogenes polypeptide und entsprechende dna fragmente
US20040236072A1 (en) * 2001-04-13 2004-11-25 Olmsted Stephen Bruce Surface proteins of streptococcus pyogenes
US7393536B2 (en) * 2001-07-06 2008-07-01 Id Biomedical Corporation Group B Streptococcus antigens and corresponding DNA fragments
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
EP1456231A2 (de) * 2001-12-20 2004-09-15 Shire Biochem Inc. Streptococcus antigene
WO2004007725A1 (en) * 2002-07-15 2004-01-22 Id Biomedical Corporation Polypeptide of streptococcus pyogenes
US20070110763A1 (en) * 2003-08-15 2007-05-17 Stephane Rioux Polypeptides of streptococcus pyogenes
CA2583803C (en) * 2004-10-08 2014-11-25 Giuliano Bensi Immunogenic and therapeutic compositions for streptococcus pyogenes
CA2611646C (en) * 2005-06-09 2015-08-11 Hansa Medical Ab Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
WO2009033670A2 (en) * 2007-09-14 2009-03-19 Genovis Ab Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection
GB201003920D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method
GB201416849D0 (en) * 2014-09-24 2014-11-05 Genovis Ab Method

Also Published As

Publication number Publication date
AU2002216863B2 (en) 2008-02-28
US8298551B2 (en) 2012-10-30
US20130136760A1 (en) 2013-05-30
US20160326221A1 (en) 2016-11-10
US8821895B2 (en) 2014-09-02
US7595057B2 (en) 2009-09-29
EP1343895B1 (de) 2008-06-18
ES2307564T9 (es) 2021-04-26
ES2307564T3 (es) 2008-12-01
AU2002216863B8 (en) 2008-03-20
DE60134494D1 (de) 2008-07-31
US20100119507A1 (en) 2010-05-13
WO2002050107A2 (en) 2002-06-27
FR21C1005I1 (de) 2021-03-26
CA2432525A1 (en) 2002-06-27
JP2004524014A (ja) 2004-08-12
AU1686302A (en) 2002-07-01
US20150017684A1 (en) 2015-01-15
CA2432525C (en) 2012-11-27
BE2021C506I2 (de) 2021-05-31
WO2002050107A3 (en) 2003-04-10
BR0116704A (pt) 2003-12-23
EP1343895A2 (de) 2003-09-17
US9340586B2 (en) 2016-05-17
US20040097706A1 (en) 2004-05-20
CA2789252A1 (en) 2002-06-27
FR21C1005I2 (fr) 2022-01-14
CA2789252C (en) 2016-11-15
JP4080876B2 (ja) 2008-04-23

Similar Documents

Publication Publication Date Title
FR21C1005I2 (fr) Antigenes de streptococcus pyogenes et fragments d'adn correspondants
ATE412750T1 (de) Antigen aus streptococcus pyogenes
WO2004030608A3 (en) Nanoemulsion vaccines
PT1487485E (pt) Adjuvantes de imidazoquinolina para vacinas de adn
MY125202A (en) Vaccine
ATE376591T1 (de) Neisseria meningitidis antigene und zusammenstellungen
MY159370A (en) Semi-soft-class immunostimulatory oligonucleotides
WO2003054007A3 (en) Streptococcus antigens
RS20050126A (en) Immunostimulatory nucleic acids
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
WO2008048344A3 (en) Bacillus anthracis antigens, vaccine compositions, and related methods
NO20030407D0 (no) Silikatformidlet syntese av omorfe silikater og siloksaner og anvendelse avdette
DE60235223D1 (de) Streptococcus pyogenes polypeptide und entsprechende dna fragmente
HK1121670A1 (en) Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
NO20025146L (no) Isolering og karakterisering av csa-operonet (ETEC-CS4 pili) og fremgangsmåter for anvendelse derav
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
DK2335720T3 (da) Autolog T-cellevacciner mod multiple sclerose
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
AU2002327795A1 (en) Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb)
WO2005013898A3 (en) Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax
WO2002079475A3 (en) Streptococcus pyogenes antigens and corresponding dna fragments
WO2002088178A8 (en) Antigens of group b streptococcus and corresponding dna fragments
DE60219021D1 (de) Immunogene zusammensetzungen die ein antigen und ein m protein des respiratorischen synzytialviruses enthalten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties